Department Of General Cardiology
Investigator
Mathew Maurer, MD
Email
msm10@cumc.columbia.edu
Mathew S. Maurer, MD - Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation. He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE). Dr. Maurer is a member of the Advanced Cardiac Care Center at NewYork Presbyterian Hospital – Columbia Campus. He is the Director of the Cardiac Amyloidosis Program.

He has published over 300 articles including peer-reviewed manuscripts, reviews, and book chapters. He was Chair of the American College of Cardiology’s Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy. Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults.

Clinical Studies Managed By This Investigator:
Condition Study Title
Heart Disease [ CLOSED ] A study on the effect of study drug GS 6615 on exercise capacity in patients Hypertrophic Cardiomyopathy HCM
Heart Disease [ CLOSED ] Drug study looking at effects of dapagliflozin on patients with Heart Failure and Preserved Ejection Fraction and diabetes or pre-diabetes.
Cardiomyopathy [ CLOSED ] Does study drug Mavacamten vs. placebo have benefit on exercise capacity in adults w/ symptomatic obstructive hypertrophic cardiomyopathy.